Delays to Low-risk Thyroid Cancer Treatment During COVID-19—Refocusing From What Has Been Lost to What May Be Learned and Gained
Brooke Nickel, Anthony Glover, Julie Ann Miller
Abstract
This Viewpoint examines the potential benefits that delaying low-risk thyroid surgical procedures may provide for patients as the coronavirus disease 2019 pandemic continues to alter treatment timelines.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Thyroid cancer2019-20 coronavirus outbreakMedicineThyroidSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CancerIntensive care medicineInternal medicineVirologyDiseaseOutbreakInfectious disease (medical specialty)Thyroid Cancer Diagnosis and TreatmentRadiation Dose and ImagingAdvances in Oncology and Radiotherapy